“Gypenosides improved inflammatory status, insulin resistance and hepatic steatosis in obese C57BL/6J mice : Gypenosides improved inflammatory status in obese mice” (2023) Journal of Food Bioactives, 21. doi:10.31665/JFB.2023.18337.